Publikationen 2024
Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohort.
BJU Int 2024; 133(5): 548-554;
Chaloupka M, Pyrgidis N, Ebner B, Volz Y, Pfitzinger PL, Berg E, Enzinger B, Atzler M, Ivanova T, Clevert DA, Buchner A, Stief CG, Apfelbeck M
The Vanishing Clinical Value of PD-L1 Status as a Predictive Biomarker in the First-Line Treatment of Urothelial Carcinoma of the Bladder.
Cancers (Basel) 2024; 16(8)
Tamalunas A, Aydogdu C, Unterrainer LM, Schott M, Rodler S, Ledderose S, Schulz GB, Stief CG, Casuscelli J
Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal.
Clin Genitourin Cancer 2024; 22(2): 189-192;
Staehler M, Rodler S, Brinkmann I, Stief CG, Graser A, Götz M, Herlemann A
mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral center.
Clin Hemorheol Microcirc 2024; 86(1-2): 63-70;
Chaloupka M, Pyrgidis N, Ebner B, Pfitzinger P, Volz Y, Berg E, Abrarova B, Atzler M, Ivanova T, Pfitzinger P, Stief CG, Apfelbeck M, Clevert DA
[68Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility study.
Eur J Nucl Med Mol Imaging 2024;
Eismann L, Ledderose ST, Enzinger B, Berg E, Westhofen T, Rodler S, Schulz GB, Toms J, Holzgreve A, Gildehaus FJ, Brendel M, Cyran CC, Unterrainer M, Stief CG, Bartenstein P, Schlenker B, Unterrainer LM
[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.
Eur J Nucl Med Mol Imaging 2024;
Unterrainer LM, Eismann L, Lindner S, Gildehaus FJ, Toms J, Casuscelli J, Holzgreve A, Kunte SC, Cyran CC, Menold P, Karl A, Unterrainer M, Ledderose ST, Stief CG, Bartenstein P, Kretschmer A, Schulz GB
Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients.
Eur Radiol 2024; 34(2): 1157-1166;
Grawe F, Blom F, Winkelmann M, Burgard C, Schmid-Tannwald C, Unterrainer LM, Sheikh GT, Pfitzinger PL, Kazmierczak P, Cyran CC, Ricke J, Stief CG, Bartenstein P, Ruebenthaler J, Fabritius MP, Geyer T
Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology.
Eur Urol 2024; 85(2): 146-153;
Eppler M, Ganjavi C, Ramacciotti LS, Piazza P, Rodler S, Checcucci E, Gomez Rivas J, Kowalewski KF, Belenchón IR, Puliatti S, Taratkin M, Veccia A, Baekelandt L, Teoh JY, Somani BK, Wroclawski M, Abreu A, Porpiglia F, Gill IS, Murphy DG, Canes D, Cacciamani GE
Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.
Eur Urol 2024; 85(6): 565-573;
Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study.
Eur Urol 2024; 85(6): 511-516
Weber M, Fendler WP, Ravi Kumar AS, Calais J, Czernin J, Ilhan H, Saad F, Kretschmer A, Hekimsoy T, Brookman-May SD, Mundle SD, Small EJ, Smith MR, Perez PM, Hope TA, Herrmann K, Hofman MS, Eiber M, Hadaschik BA
Isoform-independent promotion of contractility and proliferation, and suppression of survival by with no lysine/K kinases in prostate stromal cells.
FASEB J 2024; 38(7)
Liu Y, Huang R, Wang R, Tamalunas A, Waidelich R, Stief CG, Hennenberg M
[Robotic-assisted harvesting of a latissimus dorsi muscle flap: a case report].
Handchir Mikrochir Plast Chir 2024;
Ehrl D, Nuernberger T, Stief C, Karcz K, Giunta RE
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
J Clin Oncol 2024;
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK, CLEAR Trial Investigators
Perioperative Outcomes of Same-Session Bilateral vs Unilateral Ureteroscopy for Stone Removal: Results from the GRAND Study.
J Endourol 2024; 38(2): 129-135;
Pyrgidis N, Chaloupka M, Ebner B, Stief C, Weinhold P, Marcon J, Schulz GB
Hyperspectral imaging for monitoring of free flaps of the oral cavity: A feasibility study.
Lasers Surg Med 2024; 56(2): 165-174;
Felicio-Briegel A, Linek M, Sroka R, Rühm A, Freymüller C, Stocker M, Baumeister P, Reichel C, Volgger V
Influence of vitamins and food on the fluorescence spectrum of human urine.
Lasers Surg Med 2024;
Chalissery P, Homann C, Stepp H, Eisel M, Aumiller M, Rühm A, Buchner A, Sroka R
[Benign prostatic syndrome - epidemiology, aetiology, diagnostic evaluation].
MMW Fortschr Med 2024; 166(8): 36-39;
Kidess M, Keller P, Tamalunas A, Askari-Motlagh D, Atzler M, Karatas D, Stadelmeier L, Stief CG, Weinhold P
[Macrohaematuria].
MMW Fortschr Med 2024; 166(3): 46-48;
Eismann L, Stief CG, Bischoff R
[Medical treatment of non-neurogenic male LUTS].
MMW Fortschr Med 2024; 166(8): 40-43;
Tamalunas A, Keller P, Götz M, Atzler M, Kidess M, Stadelmeier L, Ebner B, Hennenberg M, Stief CG, Weinhold P
Update gutartige Prostatavergrößerung. Editorial.
MMW Fortschr Med 2024; 166(8);
Stief CG
Assessing Stress Induced by Fluid Shifts and Reduced Cerebral Clearance during Robotic-Assisted Laparoscopic Radical Prostatectomy under Trendelenburg Positioning (UroTreND Study).
Methods Protoc 2024; 7(2)
Peschke T, Feuerecker M, Siegl D, Schicktanz N, Stief C, Zu Eulenburg P, Choukér A, Buchheim JI
Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle.
Naunyn Schmiedebergs Arch Pharmacol 2024; 397(2): 1219-1231;
Hu S, Trieb M, Huang R, Tamalunas A, Keller P, Götz M, Waidelich R, Stief CG, Hennenberg M
Photodiagnosis Photodyn Ther 2024; 45()
Aumiller M, Arazar A, Sroka R, Dietrich O, Rühm A
Prostate 2024; 84(2): 131-147;
Wang L, Lyu C, Stadlbauer B, Buchner A, Nößner E, Pohla H
Prostate Cancer Prostatic Dis 2024;
Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, Checcucci E, Amparore D, Haiquel L, Rodriguez-Sanchez L, Ploussard G, Qiang P, Affentranger A, Marquis A, Marra G, Ettala O, Zattoni F, Falagario UG, De Angelis M, Kesch C, Apfelbeck M, Al-Hammouri T, Kretschmer A, Kasivisvanathan V, Preisser F, Lefebvre E, Olivier J, Radtke JP, Carrieri G, Moro FD, Boström P, Jambor I, Gontero P, Chiu PK, John H, Macek P, Porpiglia F, Hermanns T, van den Bergh RCN, van Basten JA, Gandaglia G, Valerio M, Young Academic Urologists working group on Prostate Cancer of the European Association of Urology
Propensity score-matched evaluation of palliative transurethral resection and holmium laser enucleation of the prostate for bladder outlet obstruction in patients with prostate cancer.
Prostate Cancer Prostatic Dis 2024;
Tamalunas A, Keller P, Schott M, Stadelmeier LF, Kidess M, Atzler M, Ebner B, Hennenberg M, Stief CG, Magistro G
Standard operating procedure to reveal prostate cancer specific volatile organic molecules by infrared spectroscopy.
Spectrochim Acta A Mol Biomol Spectrosc 2024; 304()
Maiti KS, Fill E, Strittmatter F, Volz Y, Sroka R, Apolonski A
Investigation on the influence of the skin tone on hyperspectral imaging for free flap surgery.
Sci Rep 2024;14(1):13979;
Pachyn E, Aumiller M, Freymüller C, Linek M, Volgger V, Buchner A, Rühm A, Sroka R
Transfusion 2024; 64(1): 29-38;
Ebner B, Fleckenstein F, Volz Y, Eismann L, Hermans J, Buchner A, Enzinger B, Weinhold P, Wichmann C, Stief CG, Humpe A, Pyrgidis N, Schulz GB
The prognostic value of perioperative platelet and leukocyte values in patients undergoing radical cystectomy: a prospective long-term cohort study.
Urol Int 2024;
Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, Eismann L, Marcon J, Stief CG, Jokisch F
Urol Int 2024; 108(1): 42-48;
Volz Y, Trappmann R, Ebner B, Eismann L, Enzinger B, Hermanns J, Pyrgidis N, Stief C, Schulz GB
Urol Oncol 2024; 42(2): 32.e9-32.e16;
Reese SW, Eismann L, White C, Villada JA, Khaleel S, Ostrovnaya I, Vazquez-Rivera K, Carlo MI, Feldman D, Lee CH, Motzer R, Voss MH, Kotecha RR, Matulewicz RS, Goh A, Coleman J, Russo P, Hakimi AA
Urologie 2024; 63(2): 176-183;
Brinkmann I, Stief CG, Marcon J
Impact of preoperative LUTS on Health-Related Quality of Life following Radical Prostatectomy - A propensity score matched longitudinal study.
Urology 2024;
Westhofen T, Feyerabend E, Buchner A, Schlenker B, Becker A, Eismann L, Rodler S, Jokisch F, Stief CG, Kretschmer A
Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy.
World J Urol 2024; 42(1)
Rodler S, Danninger D, Eismann L, Kazmierczak PM, Jokisch F, Li M, Becker A, Kretschmer A, Stief C, Westhofen T
The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data.
World J Urol 2024; 42(1)
Pyrgidis N, Volz Y, Ebner B, Kazmierczak PM, Enzinger B, Hermans J, Buchner A, Stief C, Schulz GB
The impact of health care on outcomes of suspected testicular torsion: results from the GRAND study.
World J Urol 2024; 42(1)
Pyrgidis N, Apfelbeck M, Stredele R, Rodler S, Kidess M, Volz Y, Weinhold P, Stief CG, Marcon J, Schulz GB, Chaloupka M
The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study.
World J Urol 2024; 42(1)
Pyrgidis N, Schulz GB, Volz Y, Ebner B, Rodler S, Westhofen T, Eismann L, Marcon J, Stief CG, Jokisch F